Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

Clinical trial NCT07035821 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07035821
Sponsor: Shanghai Children's Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients Pediatric Cancer

Start date: 2025-07-01
Primary completion: 2026-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.